Rutin

CAS# 153-18-4

Rutin

Catalog No. BCN1684----Order now to get a substantial discount!

Product Name & Size Price Stock
Rutin: 5mg Please Inquire In Stock
Rutin: 10mg Please Inquire In Stock
Rutin: 20mg Please Inquire Please Inquire
Rutin: 50mg Please Inquire Please Inquire
Rutin: 100mg Please Inquire Please Inquire
Rutin: 200mg Please Inquire Please Inquire
Rutin: 500mg Please Inquire Please Inquire
Rutin: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of Rutin

Number of papers citing our products

Chemical structure

Rutin

3D structure

Chemical Properties of Rutin

Cas No. 153-18-4 SDF Download SDF
PubChem ID 5280805 Appearance Yellow powder
Formula C27H30O16 M.Wt 610.5
Type of Compound Flavonoids Storage Desiccate at -20°C
Synonyms Rutoside; Quercetin 3-O-rutinoside
Solubility DMSO : ≥ 35 mg/mL (57.33 mM)
*"≥" means soluble, but saturation unknown.
Chemical Name 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
SMILES CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O
Standard InChIKey IKGXIBQEEMLURG-NVPNHPEKSA-N
Standard InChI InChI=1S/C27H30O16/c1-8-17(32)20(35)22(37)26(40-8)39-7-15-18(33)21(36)23(38)27(42-15)43-25-19(34)16-13(31)5-10(28)6-14(16)41-24(25)9-2-3-11(29)12(30)4-9/h2-6,8,15,17-18,20-23,26-33,35-38H,7H2,1H3/t8-,15+,17-,18+,20+,21-,22+,23+,26+,27-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Rutin

1 Achillea sp. 2 Adiantum sp. 3 Aesculus sp. 4 Aethusa sp. 5 Alkanna sp. 6 Amaranthus sp. 7 Anagallis sp. 8 Anchusa sp. 9 Arctium sp. 10 Arctostaphylos sp. 11 Artemisia sp. 12 Arum sp. 13 Asclepias sp. 14 Asparagus sp. 15 Astrantia sp. 16 Atropa sp. 17 Baptisia sp. 18 Barosma sp. 19 Begonia sp. 20 Betula sp. 21 Bidens sp. 22 Bridelia sp. 23 Bupleurum sp. 24 Calendula sp. 25 Capsella sp. 26 Carex sp. 27 Castanea sp. 28 Casuarina sp. 29 Ceanothus sp. 30 Chaerophyllum sp. 31 Cicuta sp. 32 Cirsium sp. 33 Coriandrum sp. 34 Cornus sp. 35 Crataegus sp. 36 Cucurbita sp. 37 Cyamopsis sp. 38 Cynara sp. 39 Dictamnus sp. 40 Echinacea sp. 41 Ephedra sp. 42 Erica sp. 43 Erythroxylum sp. 44 Eucalyptus sp. 45 Euphorbia sp. 46 Euphrasia sp. 47 Fagopyrum sp. 48 Fallopia sp. 49 Ficus sp. 50 Filipendula sp. 51 Flueggea sp. 52 Foeniculum sp. 53 Fragaria sp. 54 Fraxinus sp. 55 Fumaria sp. 56 Galium sp. 57 Geranium sp. 58 Ginkgo sp. 59 Globularia sp. 60 Glycyrrhiza sp. 61 Gossypium sp. 62 Hedera sp. 63 Heterotheca sp. 64 Humulus sp. 65 Hyoscyamus sp. 66 Hypericum sp. 67 Ilex sp. 68 Illicium sp. 69 Juniperus sp. 70 Lamium sp. 71 Larrea sp. 72 Laurus sp. 73 Leonurus sp. 74 Lepidium sp. 75 Liquidambar sp. 76 Liriodendron sp. 77 Lithospermum sp. 78 Lycium sp. 79 Lycopus sp. 80 Lysimachia sp. 81 Mallotus sp. 82 Malus sp. 83 Mentzelia sp. 84 Menyanthes sp. 85 Meum sp. 86 Morinda sp. 87 Moringa sp. 88 Morus sp. 89 Nerium sp. 90 Oenothera sp. 91 Olea sp. 92 Ononis sp. 93 Orchis sp. 94 Phyllanthus sp. 95 Pimpinella sp. 96 Platanus sp. 97 Polygala sp. 98 Primula sp. 99 Pterocarpus sp. 100 Rheum sp. 101 Ribes sp. 102 Rosa sp. 103 Ruscus sp. 104 Ruta sp. 105 Sambucus sp. 106 Sanguisorba sp. 107 Sanicula sp. 108 Selenicereus sp. 109 Senecio sp. 110 Serenoa sp. 111 Solidago sp. 112 Sophora sp. 113 Theobroma sp. 114 Tilia sp. 115 Uncaria sp. 116 Urtica sp. 117 Verbascum sp. 118 Vinca sp. 119 Viola sp. 120 Zanthoxylum sp.

Biological Activity of Rutin

DescriptionRutin has antioxidant, anti-inflammatory, anti-allergic, gastroprotective, anticonvulsant, anti-angiogenic and antiviral properties, it may protect against spatial memory impairment induced by trimethyltin. Rutin exerts anti-inflammatory effects in UVB-irradiated mouse skin by inhibiting expression of COX-2 and iNOS, which is attributable to its suppression of p38 MAP kinase and JNK signaling responsible for AP-1 activation.
TargetsCOX | NOS | p38MAPK | JNK | AP-1 | TGF-β/Smad | NF-kB | ERK | Nrf2 | HO-1 | p53 | IL Receptor
In vitro

Rutin content in buckwheat (Fagopyrum esculentum Moench) food materials and products[Reference: WebLink]

Food Chem., 2006, 98(3):508-12.

The Rutin content of buckwheat products was compared to the Rutin content in their raw materials, in order to evaluate their value for producing functional foods.
METHODS AND RESULTS:
There is much less Rutin in noodles (78 mg/kg, d.w.b. – dry weight basis), than in the dark buckwheat flour (218 mg/kg, d.w.b.) from which they are produced. One of the possible explanations is the presence of the Rutin degrading enzyme. In raw (uncooked) groats there is 230 mg/kg (d.w.b.) of Rutin and in precooked groats, 88 mg/kg (d.w.b.). In buckwheat beer and vinegar there is a negligible content of Rutin.
CONCLUSIONS:
Buckwheat leaf flour contains about 2700 mg/kg (d.w.b.) Rutin, and is thus a suitable material for enriching functional foods, giving it the potential for preventive nutrition.

In vivo

Rutin inhibits UVB radiation-induced expression of COX-2 and iNOS in hairless mouse skin: p38 MAP kinase and JNK as potential targets.[Pubmed: 24875145]

Arch Biochem Biophys. 2014 Oct 1;559:38-45.

Exposure to ultraviolet B (UVB) radiation, a complete environmental carcinogen, induces oxidative and inflammatory skin damage, thereby increasing the risk of skin carcinogenesis. The antioxidant and anti-inflammatory activities of a wide variety of plant polyphenols have been reported. Rutin (3-rhamnosyl-glucosylquercetin), a polyphenol present in many edible plants, possesses diverse pharmacological properties including antioxidant, anti-inflammatory, antimutagenic and anticancer activities.
METHODS AND RESULTS:
The present study was aimed to investigate the effects of Rutin on UVB-induced inflammation in mouse skin in vivo. Topical application of Rutin onto the dorsal skin of female HR-1 hairless mice 30 min prior to UVB irradiation diminished epidermal hyperplasia and the levels of proteins modified by 4-hydroxynonenal, which is a biochemical hallmark of lipid peroxidation. Topical application of Rutin also significantly inhibited UVB-induced expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), two representative inflammatory enzymes, in hairless mouse skin. Rutin inhibited the DNA binding of activator protein-1 (AP-1) and phosphorylation of signal transducer and activator of transcription-3 (STAT3) in mouse skin exposed to UVB. Moreover, Rutin attenuated UVB-induced phosphorylation of p38 mitogen-activated protein (MAP) kinase and c-Jun-N-terminal kinase (JNK). Pharmacological inhibition of p38 MAP kinase and JNK decreased UVB-induced expression of COX-2 in mouse skin.
CONCLUSIONS:
Taken together, these findings suggest that Rutin exerts anti-inflammatory effects in UVB-irradiated mouse skin by inhibiting expression of COX-2 and iNOS, which is attributable to its suppression of p38 MAP kinase and JNK signaling responsible for AP-1 activation.

Effect of quercetin and rutin in some acute seizure models in mice.[Pubmed: 24857758]

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Oct 3;54:50-8.

Quercetin is one of the most widely occurring flavonoid which is also often present in plants as glycosidic form - Rutin. These compounds are ingredients of plant diet and are also present in numerous pharmaceutical preparations and diet supplements which are taken by patients suffering from epilepsy and treating with antiepileptic drugs (AEDs). Influence of these compounds on central nervous system-related effects was proved both in experimental and clinical studies. Their influence on anxiety, depression, memory processes and convulsant activity was reported.
METHODS AND RESULTS:
The aim of the present study was to investigate the effect of quercetin and Rutin in some models of seizures, i.e., in the model of psychomotor seizures induced by 6Hz stimulation, in the maximal electroshock seizure threshold and intravenous pentylenetetrazole tests in mice. We also examined a possible mechanism of anticonvulsant activity of quercetin and its influence on action of two AEDs, i.e., valproic acid and levetiracetam, in the 6Hz seizure test. Our results revealed only a weak anticonvulsant potential of the studied flavonoids because they showed anticonvulsant action at doses from 10 to 200mg/kg only in the 6Hz test and did not change seizure thresholds in the remaining tests. Moreover, anticonvulsant action of the studied flavonoids was short-term, noted only at pretreatment time ranging between 30 and 60min. The highest anticonvulsant activity of quercetin was correlated with its high plasma and brain concentration, which was revealed in a pharmacokinetic study. We did not note changes in the anticonvulsant action of the used AEDs combined with quercetin in the model of psychomotor seizures in mice. Neither quercetin and Rutin nor combinations of quercetin with the studied AEDs produced any significant impairments of motor coordination (assessed in the chimney test), muscular strength (investigated in the grip-strength test) and long-term memory (evaluated in the passive avoidance test) in mice.
CONCLUSIONS:
The results of the present study suggest that quercetin and Rutin have only weak and short-term anticonvulsant potential. These flavonoids seem to be safe for patients with epilepsy because they neither changed activity of the studied AEDs nor produced any adverse effects.

Rutin protects the neural damage induced by transient focal ischemia in rats.[Pubmed: 19631195]

Brain Res. 2009 Oct 6;1292:123-35.

Free radical induced neural damage is implicated in cerebral ischemia-reperfusion (IR) injury and antioxidants are reported to have neuroprotective activity.
METHODS AND RESULTS:
The present study was designed to assess the neuroprotective role of Rutin (Vitamin P), and mechanism of action. The middle cerebral artery (MCA) of an adult male Wistar rat was occluded for 2 h and reperfused for 22 h. The administration of Rutin (25 mg/kg bwt., orally) once daily for 21 days before middle cerebral artery occlusion (MCAO) showed marked reduction in infarct size, reduced the neurological deficits in terms of behaviors, suppressed neuronal loss and diminished the p53 expression in MCAO rats. A significantly depleted activity of antioxidant enzymes, glutathione peroxidase (GPx), glutathione reductase (GR), catalase (CAT) and superoxide dismutase (SOD) and content of glutathione (GSH) in MCAO group were protected significantly in MCAO group pretreated with Rutin. Conversely, the elevated level of thiobarbituric acid reactive species (TBARS), H(2)O(2) and protein carbonyl (PC) in MCAO group was attenuated significantly in Rutin-pretreated group when compared with MCAO group.
CONCLUSIONS:
These results indicate that Rutin attenuates ischemic neural apoptosis by reducing the expression of p53, preventing morphological changes and increasing endogenous antioxidant enzymatic activities. Thus, Rutin treatment may represent a novel approach in lowering the risk or improving the function of ischemia-reperfusion brain injury-related disorders.

Protocol of Rutin

Animal Research

Protective effects of rutin on liver injury induced by biliary obstruction in rats.[Pubmed: 24815012]

Synaptophysin and the dopaminergic system in hippocampus are involved in the protective effect of rutin against trimethyltin-induced learning and memory impairment.[Pubmed: 24001577]

Nutr Neurosci. 2014 Sep;17(5):222-9.

This study aimed to investigate the protective effect of Rutin against trimethyltin-induced spatial learning and memory impairment in mice. This study focused on the role of synaptophysin, growth-associated protein 43 and the action of the dopaminergic system in mechanisms associated with Rutin protection and trimethyltin-induced spatial learning and memory impairment.
METHODS AND RESULTS:
Cognitive learning and memory was measured by Morris Water Maze. The expression of synaptophysin and growth-associated protein 43 in hippocampus was analyzed by western blot. The concentrations of dopamine, homovanillic acid, and dihyroxyphenylacetic acid in hippocampus were detected using reversed phase high-performance liquid chromatography with electrochemical detection. Trimethyltin-induced spatial learning impairment showed a dose-dependent mode. Synaptophysin but not growth-associated protein 43 was decreased in the hippocampus after trimethyltin administration. The concentration of dopamine decreased, while homovanillic acid increased in the hippocampus after trimethyltin administration. Mice pretreated with 20 mg/kg of Rutin for 7 consecutive days exhibited improved water maze performance. Moreover, Rutin pretreatment reversed the decrease of synaptophysin expression and dopamine alteration.
CONCLUSIONS:
These results suggest that Rutin may protect against spatial memory impairment induced by trimethyltin. Synaptophysin and the dopaminergic system may be involved in trimethyltin-induced neuronal damage in hippocampus.

Free Radic Biol Med. 2014 Aug;73:106-16.

Rutin has been shown to possess beneficial health effects, including hepatoprotection. However, to date, it has not been demonstrated to have a hepatoprotective effect against cholestatic liver injury. This is the first report to show a protective effect of Rutin on cholestatic liver injury.
METHODS AND RESULTS:
Cholestasis was produced by bile duct ligation (BDL) in male Sprague-Dawley rats for 3 weeks. Daily oral administration of Rutin was started 1 week before injury and was maintained for 4 weeks. In comparison with the control group, the BDL group showed liver injury as evidenced by histological changes and elevation in serum biochemicals, ductular reaction, fibrosis, inflammation, and oxidative stress. These pathophysiological changes were attenuated by Rutin supplementation. Rutin alleviated BDL-induced transforming growth factor β1 (TGF-β1), interleukin-1β, connective tissue growth factor, and collagen expression. The antifibrotic effect of Rutin was accompanied by reductions in α-smooth muscle actin-positive matrix-producing cells and Smad2/3 activity critical to the fibrogenic potential of TGF-β1. Rutin attenuated BDL-induced oxidative stress, leukocyte accumulation, NF-κB activation, and proinflammatory cytokine production. Further studies demonstrated an inhibitory effect of Rutin on the redox-sensitive intracellular signaling molecule extracellular signal-regulated kinase (ERK). Rutin also attenuated BDL-induced reduction in NF-E2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), and AMP-activated protein kinase (AMPK).
CONCLUSIONS:
Taken together, the beneficial effects of Rutin were shown to be associated with antioxidative and anti-inflammatory effects as well as the downregulation of NF-κB and TGF-β/Smad signaling, probably via interference of ERK activation and/or enhancement of Nrf2, HO-1, and AMPK activity.

Rutin Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Rutin Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Rutin

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.638 mL 8.19 mL 16.38 mL 32.76 mL 40.95 mL
5 mM 0.3276 mL 1.638 mL 3.276 mL 6.552 mL 8.19 mL
10 mM 0.1638 mL 0.819 mL 1.638 mL 3.276 mL 4.095 mL
50 mM 0.0328 mL 0.1638 mL 0.3276 mL 0.6552 mL 0.819 mL
100 mM 0.0164 mL 0.0819 mL 0.1638 mL 0.3276 mL 0.4095 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Rutin

Rutin, a naturally occurring flavonoid glycoside, has antioxidant, anti-inflammatory, anti-allergic, anti-angiogenic and antiviral properties.

References:
[1]. E. H. Aksu, et al. Rutin ameliorates cisplatin-induced reproductive damagevia suppression of oxidative stress and apoptosis in adultmale rats. Andrologia. 2016 Apr 23. [2]. Han YH, et al. Lipin1-Mediated Repression of Adipogenesis by Rutin.Am J Chin Med. 2016;44(3):565-78 [3]. Lu N, et al. Effects of rutin on the redox reactions of hemoglobin. Int J Biol Macromol. 2016 Apr 25;89:175-180.

Featured Products
New Products
 

References on Rutin

Effect of quercetin and rutin in some acute seizure models in mice.[Pubmed:24857758]

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Oct 3;54:50-8.

Quercetin is one of the most widely occurring flavonoid which is also often present in plants as glycosidic form - Rutin. These compounds are ingredients of plant diet and are also present in numerous pharmaceutical preparations and diet supplements which are taken by patients suffering from epilepsy and treating with antiepileptic drugs (AEDs). Influence of these compounds on central nervous system-related effects was proved both in experimental and clinical studies. Their influence on anxiety, depression, memory processes and convulsant activity was reported. The aim of the present study was to investigate the effect of quercetin and Rutin in some models of seizures, i.e., in the model of psychomotor seizures induced by 6Hz stimulation, in the maximal electroshock seizure threshold and intravenous pentylenetetrazole tests in mice. We also examined a possible mechanism of anticonvulsant activity of quercetin and its influence on action of two AEDs, i.e., valproic acid and levetiracetam, in the 6Hz seizure test. Our results revealed only a weak anticonvulsant potential of the studied flavonoids because they showed anticonvulsant action at doses from 10 to 200mg/kg only in the 6Hz test and did not change seizure thresholds in the remaining tests. Moreover, anticonvulsant action of the studied flavonoids was short-term, noted only at pretreatment time ranging between 30 and 60min. The highest anticonvulsant activity of quercetin was correlated with its high plasma and brain concentration, which was revealed in a pharmacokinetic study. We did not note changes in the anticonvulsant action of the used AEDs combined with quercetin in the model of psychomotor seizures in mice. Neither quercetin and Rutin nor combinations of quercetin with the studied AEDs produced any significant impairments of motor coordination (assessed in the chimney test), muscular strength (investigated in the grip-strength test) and long-term memory (evaluated in the passive avoidance test) in mice. The results of the present study suggest that quercetin and Rutin have only weak and short-term anticonvulsant potential. These flavonoids seem to be safe for patients with epilepsy because they neither changed activity of the studied AEDs nor produced any adverse effects.

Rutin protects the neural damage induced by transient focal ischemia in rats.[Pubmed:19631195]

Brain Res. 2009 Oct 6;1292:123-35.

Free radical induced neural damage is implicated in cerebral ischemia-reperfusion (IR) injury and antioxidants are reported to have neuroprotective activity. The present study was designed to assess the neuroprotective role of Rutin (Vitamin P), and mechanism of action. The middle cerebral artery (MCA) of an adult male Wistar rat was occluded for 2 h and reperfused for 22 h. The administration of Rutin (25 mg/kg bwt., orally) once daily for 21 days before middle cerebral artery occlusion (MCAO) showed marked reduction in infarct size, reduced the neurological deficits in terms of behaviors, suppressed neuronal loss and diminished the p53 expression in MCAO rats. A significantly depleted activity of antioxidant enzymes, glutathione peroxidase (GPx), glutathione reductase (GR), catalase (CAT) and superoxide dismutase (SOD) and content of glutathione (GSH) in MCAO group were protected significantly in MCAO group pretreated with Rutin. Conversely, the elevated level of thiobarbituric acid reactive species (TBARS), H(2)O(2) and protein carbonyl (PC) in MCAO group was attenuated significantly in Rutin-pretreated group when compared with MCAO group. These results indicate that Rutin attenuates ischemic neural apoptosis by reducing the expression of p53, preventing morphological changes and increasing endogenous antioxidant enzymatic activities. Thus, Rutin treatment may represent a novel approach in lowering the risk or improving the function of ischemia-reperfusion brain injury-related disorders.

Rutin inhibits UVB radiation-induced expression of COX-2 and iNOS in hairless mouse skin: p38 MAP kinase and JNK as potential targets.[Pubmed:24875145]

Arch Biochem Biophys. 2014 Oct 1;559:38-45.

Exposure to ultraviolet B (UVB) radiation, a complete environmental carcinogen, induces oxidative and inflammatory skin damage, thereby increasing the risk of skin carcinogenesis. The antioxidant and anti-inflammatory activities of a wide variety of plant polyphenols have been reported. Rutin (3-rhamnosyl-glucosylquercetin), a polyphenol present in many edible plants, possesses diverse pharmacological properties including antioxidant, anti-inflammatory, antimutagenic and anticancer activities. The present study was aimed to investigate the effects of Rutin on UVB-induced inflammation in mouse skin in vivo. Topical application of Rutin onto the dorsal skin of female HR-1 hairless mice 30 min prior to UVB irradiation diminished epidermal hyperplasia and the levels of proteins modified by 4-hydroxynonenal, which is a biochemical hallmark of lipid peroxidation. Topical application of Rutin also significantly inhibited UVB-induced expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), two representative inflammatory enzymes, in hairless mouse skin. Rutin inhibited the DNA binding of activator protein-1 (AP-1) and phosphorylation of signal transducer and activator of transcription-3 (STAT3) in mouse skin exposed to UVB. Moreover, Rutin attenuated UVB-induced phosphorylation of p38 mitogen-activated protein (MAP) kinase and c-Jun-N-terminal kinase (JNK). Pharmacological inhibition of p38 MAP kinase and JNK decreased UVB-induced expression of COX-2 in mouse skin. Taken together, these findings suggest that Rutin exerts anti-inflammatory effects in UVB-irradiated mouse skin by inhibiting expression of COX-2 and iNOS, which is attributable to its suppression of p38 MAP kinase and JNK signaling responsible for AP-1 activation.

Synaptophysin and the dopaminergic system in hippocampus are involved in the protective effect of rutin against trimethyltin-induced learning and memory impairment.[Pubmed:24001577]

Nutr Neurosci. 2014 Sep;17(5):222-9.

OBJECTIVES: This study aimed to investigate the protective effect of Rutin against trimethyltin-induced spatial learning and memory impairment in mice. This study focused on the role of synaptophysin, growth-associated protein 43 and the action of the dopaminergic system in mechanisms associated with Rutin protection and trimethyltin-induced spatial learning and memory impairment. METHODS: Cognitive learning and memory was measured by Morris Water Maze. The expression of synaptophysin and growth-associated protein 43 in hippocampus was analyzed by western blot. The concentrations of dopamine, homovanillic acid, and dihyroxyphenylacetic acid in hippocampus were detected using reversed phase high-performance liquid chromatography with electrochemical detection. RESULTS: Trimethyltin-induced spatial learning impairment showed a dose-dependent mode. Synaptophysin but not growth-associated protein 43 was decreased in the hippocampus after trimethyltin administration. The concentration of dopamine decreased, while homovanillic acid increased in the hippocampus after trimethyltin administration. Mice pretreated with 20 mg/kg of Rutin for 7 consecutive days exhibited improved water maze performance. Moreover, Rutin pretreatment reversed the decrease of synaptophysin expression and dopamine alteration. DISCUSSION: These results suggest that Rutin may protect against spatial memory impairment induced by trimethyltin. Synaptophysin and the dopaminergic system may be involved in trimethyltin-induced neuronal damage in hippocampus.

Protective effects of rutin on liver injury induced by biliary obstruction in rats.[Pubmed:24815012]

Free Radic Biol Med. 2014 Aug;73:106-16.

Rutin has been shown to possess beneficial health effects, including hepatoprotection. However, to date, it has not been demonstrated to have a hepatoprotective effect against cholestatic liver injury. This is the first report to show a protective effect of Rutin on cholestatic liver injury. Cholestasis was produced by bile duct ligation (BDL) in male Sprague-Dawley rats for 3 weeks. Daily oral administration of Rutin was started 1 week before injury and was maintained for 4 weeks. In comparison with the control group, the BDL group showed liver injury as evidenced by histological changes and elevation in serum biochemicals, ductular reaction, fibrosis, inflammation, and oxidative stress. These pathophysiological changes were attenuated by Rutin supplementation. Rutin alleviated BDL-induced transforming growth factor beta1 (TGF-beta1), interleukin-1beta, connective tissue growth factor, and collagen expression. The antifibrotic effect of Rutin was accompanied by reductions in alpha-smooth muscle actin-positive matrix-producing cells and Smad2/3 activity critical to the fibrogenic potential of TGF-beta1. Rutin attenuated BDL-induced oxidative stress, leukocyte accumulation, NF-kappaB activation, and proinflammatory cytokine production. Further studies demonstrated an inhibitory effect of Rutin on the redox-sensitive intracellular signaling molecule extracellular signal-regulated kinase (ERK). Rutin also attenuated BDL-induced reduction in NF-E2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), and AMP-activated protein kinase (AMPK). Taken together, the beneficial effects of Rutin were shown to be associated with antioxidative and anti-inflammatory effects as well as the downregulation of NF-kappaB and TGF-beta/Smad signaling, probably via interference of ERK activation and/or enhancement of Nrf2, HO-1, and AMPK activity.

Description

Rutin, a naturally occurring flavonoid glycoside, has antioxidant, anti-inflammatory, anti-allergic, anti-angiogenic and antiviral properties.

Keywords:

Rutin,153-18-4,Rutoside; Quercetin 3-O-rutinoside,Natural Products, buy Rutin , Rutin supplier , purchase Rutin , Rutin cost , Rutin manufacturer , order Rutin , high purity Rutin

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: